© 1988 by Oxford University Press
Journal of the National Cancer Institute, Vol. 80, No. 9, 683-687,
July 6, 1988
© 1988 Oxford University Press
Trends in Frequency of Latent Prostate Carcinoma in Japan from 1965–1979 to 1982–19862
3Department of Pathology, Mie University School of medicine 2-174 Edobashi, Tsu Mie 514, Japan.
4Department of Pathology, Fukui Medical School Matsuoka, Fukui, Japan
5Laboratory Department, Kuakini Medical Center Honolulu, HI
6Japan-Hawaii Cancer Study Honolulu, HI
By analyzing serial step-sections of whole prostate obtained at autopsy, we determined the chronologic change of the frequency of latent prostate tumor in Japan in two periods: 1965–1979 and 1982–1986. Methods of specimen preparation and examination were identical for both periods. The frequency with which latent prostate carcinoma was found in the 660 samples for 1982–1986 was 34.6% and was significantly higher than the 22.5% seen in the 576 observed for 1965–1979 (P<.0001). This significant finding can be attributed to an increase in the frequency of latent infiltrative tumor (LIT). However, the increase in the frequency of noninfiltrative tumor (LNT) was less significant (P=.045). Both sets of specimens were subsequently combined and reanalyzed according to the year of birth of the decedents. The LIT has progressively increased in frequency in each age-specific category. By morphometry, we determined that the mean tumor volume decreased due to an increase in the number of smaller tumors during the study periods. Although the frequency of latent prostate carcinoma and the LIT: LNT in the samples obtained most recently were comparable to those of U.S. whites, cancer incidence and mortality rates remain lower in Japan. Apparently, the initial step in the induction of prostate carcinoma in indigenous Japanese is now similar to that in U.S. whites. The rates of clinical carcinoma in Japan are still low when compared with those in the United States and countries in Western Europe, but our findings may presage a time when these differences may be greatly reduced or nonexistent. [J Natl Cancer Inst 1988; 80: 683–687]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Tsujimoto, Y. Tomita, Y. Hoshida, T. Kono, T. Oka, S. Yamamoto, N. Nonomura, A. Okuyama, and K. Aozasa Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate Cancer Clin. Cancer Res., May 1, 2004; 10(9): 3007 - 3012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kakehi Watchful Waiting as a Treatment Option for Localized Prostate Cancer in the PSA Era Jpn. J. Clin. Oncol., January 1, 2003; 33(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Ou, J.-T. Chen, C.-R. Yang, C.-L. Cheng, H.-C. Ho, J.-L. Ko, and Y.-S. Hsieh Predicting Prostate Specific Antigen Failure after Radical Retropubic Prostatectomy for T1c Prostate Cancer Jpn. J. Clin. Oncol., December 1, 2002; 32(12): 536 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Ou, J.-T. Chen, C.-R. Yang, C.-L. Cheng, H.-C. Ho, Y.-L. Kao, J.-L. Ko, and Y.-S. Hsieh Preoperative Prediction of Extracapsular Tumor Extension at Radical Retropubic Prostatectomy in Taiwanese Patients with T1c Prostate Cancer Jpn. J. Clin. Oncol., May 1, 2002; 32(5): 172 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marcelli and G. R. Cunningham Hormonal Signaling in Prostatic Hyperplasia and Neoplasia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3463 - 3468. [Full Text] [PDF]
|
|